Udaipur, India — In a landmark achievement for Indian medical technology, SS Innovations International, Inc., the creators of the pioneering SSI Mantra surgical robotic system, has officially debuted on NASDAQ. Trading began on April 25, 2025, under the ticker symbol ‘SSII’, marking a major step in the company’s global expansion journey.
Record-Breaking Financial Performance Fuels Global Aspirations
SS Innovations International closed the fiscal year ending December 31, 2024, with impressive financial results. The company reported revenues of $20.6 million, a 3.5-times increase from $5.9 million in 2023. In addition, gross margins rose significantly to 40.9% from 12.3%, reflecting strong operational efficiency and increased market demand for its products.
The growth trajectory underscores SS Innovations’ successful efforts to position the SSI Mantra as a globally competitive alternative in the surgical robotics market.
SSI Mantra: Pioneering Affordable Robotic Surgery
Founded by Dr. Sudhir Srivastava, SS Innovations International has gained international acclaim with its SSI Mantra Surgical Robotic System — an indigenous innovation offering high-quality, safe, efficient, and cost-effective robotic surgery solutions. The system is designed to make cutting-edge robotic surgery accessible to a broader range of patients, both in India and worldwide.
Commenting on the milestone, Dr. Srivastava said, “Uplisting to NASDAQ marks an exciting milestone for SS Innovations International and reflects our team’s achievements in developing the world-class SSI Mantra Surgical Robotic System. As a proud ‘Made in India for the world’ innovation, we are helping elevate India’s presence in the global healthcare landscape.”
Elevating India’s Status in Global Healthcare Innovation
The debut of SS Innovations International on NASDAQ is not only a corporate success but also a testament to India’s evolving prowess in high-end healthcare technologies. It places India firmly on the map of cutting-edge medical innovation, with the SSI Mantra poised to challenge more expensive international robotic surgery systems.
As the company sets its sights on further global expansion, SS Innovations International’s NASDAQ listing is expected to catalyze new partnerships, innovation initiatives, and broader access to affordable robotic healthcare solutions.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
